Related Experiment Videos
Streptomycin perfusion of the labyrinth
1Shea Clinic, Shea Clinic Foundation, Memphis, Tennessee.
Abstract:
The combination of fluctuant hearing loss, fullness, tinnitus and dizzy spells we call Meniere's disease is thought to be caused by endolymphatic hydrops. Most patients with the clinical picture of Meniere's disease do have endolymphatic hydrops but some patients with endolymphatic hydrops do not have the clinical picture of Meniere's disease. It would appear there is an, as yet unknown, immune-mediated, cause for Meniere's disease, in addition to endolymphatic hydrops, and this immune-mediated cause may aggravate those ears with endolymphatic hydrops. While medical treatment with a low-salt diet, diuretics and steroids are of value in some patients when given early in controlling dizzy spells and improving the hearing, there is usually no real, long-term benefit. Since none of these "shunts" of the sac could remain open for more than a few hours, they could have no more direct benefit than a one-time drainage of endolymph, while doing harm to the fluid absorption, immune response and phagocytosis roles of the endolymphatic sac. The various vestibular neurectomy operations, while usually stopping the dizzy attacks, are both difficult and potentially dangerous, but more important, do nothing for the hearing loss. The one direct attack on the problem, both easy to perform and certain to relieve the dizzy attacks, is to destroy the vestibular receptors with streptomycin. This destructive action on the stereocilia and sensory cells, without damage to the rest of the vestibular system and the cochlea, has been verified by two cat experiments with streptomycin by Norris et al. and Norris & Shea and two guinea pig experiments with gentamicin by Kimura.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Meniere's disease may involve an immune cause beyond endolymphatic hydrops. Streptomycin offers a direct treatment for dizzy spells by destroying vestibular receptors without harming hearing.
Area of Science:
- Otolaryngology
- Neurology
- Immunology
Background:
- Meniere's disease is characterized by hearing loss, tinnitus, and vertigo.
- Endolymphatic hydrops is the presumed cause, but not all cases align.
- An unknown immune-mediated factor may contribute to Meniere's disease.
Purpose of the Study:
- To explore potential causes of Meniere's disease beyond endolymphatic hydrops.
- To evaluate the efficacy of current treatments for Meniere's disease.
- To investigate streptomycin as a direct treatment for Meniere's disease symptoms.
Main Methods:
- Review of clinical presentations and pathological findings in Meniere's disease.
- Analysis of the effectiveness of medical (diet, diuretics, steroids) and surgical treatments.
- Examination of streptomycin's effect on vestibular receptors, referencing animal studies.
Main Results:
- Endolymphatic hydrops is present in most, but not all, Meniere's disease patients.
- Conventional treatments offer limited long-term benefit for vertigo and hearing loss.
- Streptomycin effectively relieves dizzy attacks by selectively destroying vestibular receptors.
Conclusions:
- Meniere's disease likely has an immune-mediated component exacerbating endolymphatic hydrops.
- Surgical interventions like vestibular neurectomy are risky and do not improve hearing.
- Streptomycin presents a direct, effective method for controlling vertigo in Meniere's disease.